tradingkey.logo

Medtronic PLC

MDT

85.280USD

+3.390+4.14%
Handelsschluss 04/09, 16:00ETKurse um 15 Minuten verzögert
111.83BMarktkapitalisierung
26.25KGV TTM

Medtronic PLC

85.280

+3.390+4.14%
mehr Informationen über Medtronic PLC Unternehmen
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Unternehmensinformationen
Unternehmens-codeMDT
Name des UnternehmensMedtronic PLC
IPO-datumNov 21, 1977
Gegründet am2014
CEOMr. Geoffrey S. (Geoff) Martha
Anzahl der mitarbeiter95000
WertpapierartOrdinary Share
GeschäftsjahresendeNov 21
AddresseBuilding Two Parkmore Business Park West
StadtDUBLIN
BörseNYSE Consolidated
LandIreland
PostleitzahlH91 4K49
Telefon1135314381700
Websitehttps://www.medtronic.com/
Unternehmens-codeMDT
IPO-datumNov 21, 1977
Gegründet am2014
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.03M
+0.45%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President and President - Cardiovascular Portfolio
Executive Vice President and President - Cardiovascular Portfolio
543.91K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
486.64K
-0.61%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
111.10K
+90.72%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Ms. Denise M. O'Leary
Ms. Denise M. O'Leary
Independent Director
Independent Director
48.75K
+0.66%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
46.09K
+2.03%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
39.00K
-1.45%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
38.30K
+0.19%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
30.75K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.03M
+0.45%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President and President - Cardiovascular Portfolio
Executive Vice President and President - Cardiovascular Portfolio
543.91K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
486.64K
-0.61%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
111.10K
+90.72%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Ms. Denise M. O'Leary
Ms. Denise M. O'Leary
Independent Director
Independent Director
48.75K
+0.66%
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Surgical & Endoscopy
1.60B
19.25%
Cardiac Rhythm & Heart Failure
1.54B
18.63%
Cranial & Spinal Technologies
1.25B
15.07%
Structural Heart & Aortic
874.00M
10.54%
Specialty Therapies
732.00M
8.83%
Other
2.29B
27.68%
Nach RegionUSD
Name
Umsatz
Anteil
United States
4.24B
51.10%
Rest of World
4.03B
48.56%
Ireland
28.00M
0.34%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Surgical & Endoscopy
1.60B
19.25%
Cardiac Rhythm & Heart Failure
1.54B
18.63%
Cranial & Spinal Technologies
1.25B
15.07%
Structural Heart & Aortic
874.00M
10.54%
Specialty Therapies
732.00M
8.83%
Other
2.29B
27.68%
Aktionäre
Update-Zeit: Tue, Mar 11
Update-Zeit: Tue, Mar 11
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
9.64%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Global Advisors (US)
4.71%
Capital Research Global Investors
2.59%
Geode Capital Management, L.L.C.
2.11%
Other
75.64%
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
9.64%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Global Advisors (US)
4.71%
Capital Research Global Investors
2.59%
Geode Capital Management, L.L.C.
2.11%
Other
75.64%
Art
Aktionäre
Anteil
Investment Advisor/Hedge Fund
39.32%
Investment Advisor
34.35%
Research Firm
3.92%
Pension Fund
2.45%
Hedge Fund
2.15%
Bank and Trust
2.10%
Sovereign Wealth Fund
1.22%
Insurance Company
0.39%
Individual Investor
0.25%
Other
13.85%
Institutionelle Beteiligung
Update-Zeit: Thu, Feb 20
Update-Zeit: Thu, Feb 20
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
3688
1.12B
87.11%
+2.87M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
2023Q1
3738
1.14B
85.40%
-14.71M
2022Q4
3689
1.13B
84.79%
-25.98M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
123.63M
9.64%
+776.44K
+0.63%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
68.04M
5.31%
+1.54M
+2.32%
Dec 31, 2024
State Street Global Advisors (US)
60.44M
4.71%
-293.90K
-0.48%
Dec 31, 2024
Capital Research Global Investors
33.20M
2.59%
+571.70K
+1.75%
Dec 31, 2024
Geode Capital Management, L.L.C.
27.06M
2.11%
+574.05K
+2.17%
Dec 31, 2024
JP Morgan Asset Management
24.34M
1.9%
+2.87M
+13.36%
Dec 31, 2024
MFS Investment Management
19.23M
1.5%
-3.64M
-15.91%
Dec 31, 2024
DWS Investment GmbH
14.66M
1.14%
+197.49K
+1.37%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
14.57M
1.14%
-1.01M
-6.49%
Dec 31, 2024
BlackRock Financial Management, Inc.
13.22M
1.03%
+764.34K
+6.14%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
Absolute Select Value ETF
6.39%
Polen Capital International Growth ETF
5.81%
Cullen Enhanced Equity Income ETF
5.03%
Madison Dividend Value ETF
4.07%
iShares U.S. Medical Devices ETF
4.01%
Madison Covered Call ETF
3.98%
American Century Focused Large Cap Value ETF
3.84%
First Trust Active Global Quality Income ETF
3.64%
JPMorgan Healthcare Leaders ETF
3.28%
USCF Dividend Income Fund
3.2%
Mehr Anzeigen
Absolute Select Value ETF
Anteil6.39%
Polen Capital International Growth ETF
Anteil5.81%
Cullen Enhanced Equity Income ETF
Anteil5.03%
Madison Dividend Value ETF
Anteil4.07%
iShares U.S. Medical Devices ETF
Anteil4.01%
Madison Covered Call ETF
Anteil3.98%
American Century Focused Large Cap Value ETF
Anteil3.84%
First Trust Active Global Quality Income ETF
Anteil3.64%
JPMorgan Healthcare Leaders ETF
Anteil3.28%
USCF Dividend Income Fund
Anteil3.2%
Dividende
In den vergangenen 5 Jahren wurden insgesamt 16.68B USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
Mar 02, 2023
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023
Mar 24, 2023
Apr 14, 2023
Mar 23, 2023
Dec 08, 2022
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022
Dec 21, 2022
Jan 13, 2023
Dec 20, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
tradingkey.logo
tradingkey.logo
Intraday-Daten werden von Refinitiv bereitgestellt und unterliegen den Nutzungsbedingungen. Historische und aktuelle End-of-Day-Daten stammen ebenfalls von Refinitiv. Alle Kursangaben entsprechen der lokalen Börsenzeit. Echtzeit-Kursdaten zu US-Aktien beziehen sich ausschließlich auf über Nasdaq gemeldete Transaktionen. Intraday-Daten sind mindestens 15 Minuten oder gemäß den Vorgaben der jeweiligen Börse verzögert.
* Referenzen, Analysen und Handelsstrategien werden vom Drittanbieter Trading Central bereitgestellt, und der Standpunkt basiert auf der unabhängigen Bewertung und Beurteilung des Analysten, ohne die Anlageziele und die finanzielle Situation der Investoren zu berücksichtigen.
Risikohinweis: Unsere Website und mobile App bieten lediglich allgemeine Informationen zu bestimmten Anlageprodukten. Finsights stellt keine Finanzberatung oder Empfehlung für ein Anlageprodukt bereit, und die Bereitstellung solcher Informationen darf nicht als Finanzberatung durch Finsights ausgelegt werden.
Anlageprodukte unterliegen erheblichen Anlagerisiken, einschließlich des möglichen Verlusts des investierten Kapitals und sind möglicherweise nicht für jeden geeignet. Die vergangene Wertentwicklung von Anlageprodukten ist nicht unbedingt ein Hinweis auf deren zukünftige Wertentwicklung.
Finsights kann Drittanbietern oder Partnern erlauben, Werbung auf unserer Website oder in unserer mobilen App oder in Teilen davon zu platzieren oder bereitzustellen. Finsights kann für diese Anzeigenvergütung erhalten, basierend auf Ihrer Interaktion mit den Werbeanzeigen.
© Urheberrecht: FINSIGHTS MEDIA PTE. LTD. Alle Rechte vorbehalten.